Upgrades
- Banco Bradesco (BBD) upgraded by Citi from Neutral to Buy
- Aedifica (AEDFF) upgraded by Kepler Cheuvreux from Hold to Buy
- Kojamo (KOJAF) upgraded by Kepler Cheuvreux from Hold to Buy
- FICO (FICO) upgraded by Baird from Neutral to Outperform
- Montea (MONSF) upgraded by Kepler Cheuvreux from Hold to Buy
- XP Inc. (XP) upgraded by Grupo Santander from Neutral to Outperform
- Barings BDC (BBDC) upgraded by Wells Fargo from Equal Weight to Overweight
- Vail Resorts (MTN) upgraded by JPMorgan from Underweight to Neutral
- Noble Corp. (NE) upgraded by JPMorgan from Neutral to Overweight
- State Street (STT) upgraded by Truist from Hold to Buy
- Allianz (ALIZY) upgraded by DBS Bank from Sell to Fully Valued
Investors Can't Afford to Miss This [sponsor]
To carry out Trump's Executive Order #14196 initiative, the administration will have to partner with a handful of U.S. companies that control the "reserve accounts" sitting on trillions of dollars' worth of untapped natural resources. I've spent months digging into this – and I've identified three companies that have already been granted "emergency status" and fast-track approvals. I believe their shares could skyrocket once new capital starts moving into the sector. See the three stocks that I expect to be the biggest winners as this plan rolls.
To carry out Trump's Executive Order #14196 initiative, the administration will have to partner with a handful of U.S. companies that control the "reserve accounts" sitting on trillions of dollars' worth of untapped natural resources. I've spent months digging into this – and I've identified three companies that have already been granted "emergency status" and fast-track approvals. I believe their shares could skyrocket once new capital starts moving into the sector. See the three stocks that I expect to be the biggest winners as this plan rolls.
Downgrades
- Boundless Bio (BOLD) downgraded by Leerink from Outperform to Market Perform
- Vigil Neuroscience (VIGL) downgraded by Stifel from Buy to Hold
- Rocket Pharmaceuticals (RCKT) downgraded by Leerink from Outperform to Market Perform
- Rocket Pharmaceuticals (RCKT) downgraded by Morgan Stanley from Overweight to Equal Weight
- Informatica (INFA) downgraded by Wolfe Research from Outperform to Peer Perform
- Par Pacific (PARR) downgraded by Goldman Sachs from Buy to Neutral
- National Grid (NGG) downgraded by RBC Capital from Outperform to Sector Perform
- Rocket Pharmaceuticals (RCKT) downgraded by Jefferies from Buy to Hold
- Booz Allen (BAH) downgraded by Goldman Sachs from Neutral to Sell
- PDD Holdings (PDD) downgraded by China Renaissance from Buy to Hold
- Skechers (SKX) downgraded by TD Cowen from Buy to Hold
- Prothena (PRTA) downgraded by BofA from Neutral to Underperform
- BNY Mellon (BK) downgraded by Truist from Buy to Hold
MAG-7 Stocks Are Dead—Here's What Killed Them [sponsor]
The old way of investing in tech giants is over. A NEW strategy unlocks 146X more income on the SAME underlying stocks (like Meta, Apple, and Amazon) -- WITHOUT options trading. Click here to uncover the NEW MAG-7 alternative.
The old way of investing in tech giants is over. A NEW strategy unlocks 146X more income on the SAME underlying stocks (like Meta, Apple, and Amazon) -- WITHOUT options trading. Click here to uncover the NEW MAG-7 alternative.
Upgrades & Downgrades provided by The Fly at http://www.thefly.com. The Fly is a leading digital publisher of real-time financial news. Our financial market experts understand that news impacting stock prices can originate from anywhere, at any time. The Fly team scours all sources of company news, from mainstream to cutting-edge, then filters out the noise to deliver short-form stories consisting of only market moving content. Become an informed investor. Try all of The Fly’s services FREE for 14 days by clicking here.